第三次伽玛刀放射外科治疗三叉神经痛的结果
该回顾性研究纳入2010至2018年在本机构接受第三次伽玛刀放射外科(GKRS)治疗的三叉神经痛(TN)患者,通过电话随访收集长期数据,采用Barrow神经病学研究所(BNI)疼痛强度量表评估结局。22根神经中18根治疗成功,疼痛缓解中位持续3.88年,与既往第一、第二次GKRS的历史对照无显著差异;10例出现新发或加重的面部麻木,4例报告其他毒性,未发现预测因素。
要点
- 第三次GKRS对再次复发后的三叉神经痛有效,22根神经中18根治疗成功。
- 疼痛缓解中位持续3.88年,与第一、第二次GKRS的历史对照无显著差异。
- 10例出现新发或加重面部麻木,非麻木毒性在第三次GKRS照射靶点位置偏近端者中更常见。
核心结论
- 第三次GKRS是重复GKRS后疼痛复发的三叉神经痛患者的有效治疗选择。
- 第三次GKRS的疼痛结局与第一次或第二次GKRS相似。
- 对于第三次GKRS照射靶点位置偏远端的患者,毒性可耐受。
研究设计与样本
- 回顾性审查本机构电子病历和GKRS数据库,识别2010年至2018年期间在本机构接受第三次GKRS治疗的患者。
- 采用电话访谈收集长期随访数据,疼痛结局使用Barrow神经病学研究所(BNI)疼痛强度量表评估,评分≤IIIb表示治疗成功。
- 共21例患者的22根神经具有足够随访以确定BNI疼痛评分结局。
主要发现
- 22根神经中18根第三次GKRS治疗成功,疼痛缓解中位持续时间为3.88年。
- 第三次GKRS后疼痛缓解持久性与本机构既往第一和第二次GKRS系列的历史对照相比无显著差异。
- 10例出现新发或加重的面部麻木,其中1例令人困扰。
- 报告4例除面部麻木以外的毒性,包括1例角膜擦伤和可能的神经滋养性角膜病变;未报告麻醉性疼痛病例。
- 未识别出预测治疗成功或疼痛缓解持久性的因素;非麻木毒性在第三次GKRS照射靶点位置偏近端者中更常见。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Gamma Knife radiosurgery (GKRS) is a commonly used procedure for medically refractory trigeminal neuralgia (TN), with repeat GKRS routinely done in cases of pain relapse. The results of a third GKRS in cases of further pain relapse have not been well described. In this study, the authors report the largest series of patients treated with a third GKRS for TN to date. METHODS: Retrospective review of institutional electronic medical records and a GKRS database was performed to identify patients who had been treated with a third GKRS at the authors' institution in the period from 2010 to 2018. Telephone interviews were used to collect long-term follow-up data. Pain outcomes were measured using the Barrow Neurological Institute (BNI) pain intensity scale, with a score ≤ IIIb indicating successful treatment. RESULTS: Twenty-two nerves in 21 patients had sufficient follow-up to determine BNI pain score outcomes. Eighteen of 22 cases had a successful third GKRS, with a median durability of pain relief of 3.88 years. There was no significant difference in the durability of pain relief after a third GKRS compared with those of institutional historical controls of prior series of first and second GKRS procedures. Ten cases had new or worsening facial numbness, with 1 case being bothersome. Four cases of toxicity other than facial numbness were reported, including 1 case of corneal abrasions and possible neurotrophic keratopathy. No cases of anesthesia dolorosa were reported. No factors predicting treatment success or the durability of pain relief were identified. Nonnumbness toxicity was more common in those with a proximally placed shot at the third GKRS. CONCLUSIONS: A third GKRS is an effective treatment option for TN patients who have pain relapse after repeat GKRS. Pain outcomes of a third GKRS are similar to those following a first or second GKRS. Toxicity is tolerable in patients with a distally placed shot at the third GKRS.
引用
- Helis CA, Hughes RT, Munley MT, et al. Results of a third Gamma Knife radiosurgery for trigeminal neuralgia. J Neurosurg. 2020. PMID: 32330887. doi:10.3171/2020.2.JNS192876
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。